Oramed Pharmaceuticals Inc. (Oramed), a pharmaceutical company, engages in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins.
The company has developed an or…
Analysis
Middle-of-the-road
Oramed Pharmaceuticals Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group. One caution: reported profits have recently run ahead of actual cash, which we track closely.
The price is attractive. You pay 1.4× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone.
The trajectory is moderate and the balance sheet is adequate. The company scores 12/20 on our value-creation score: creating some value. Analysts lean positive.
What to watch: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Mar 202623
40
2026
All-time high
40
Jun 2026
All-time low
23
Mar 2026
Average rank
32
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
1
—
—
—
Price/Earnings
100
—
—
—
Price/Book
92
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
96
—
—
—
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.